GlaxoSmithKline plc Bets Big On Africa

GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has ploughed £125m into its African manufacturing and research operations. Here, Owain Bennallack analyses this decision…

GlaxoSmithKline is one of five shares in the FTSE 100 that our top analysts have highlighted in our special report "5 Shares To Retire On". To find out the reasons behind their inclusion, and the names of the other four shares, simply click here to have it delivered competely free to your inbox.

Owain owns shares in GlaxoSmithKline. The Motley Fool has recommended shares in GlaxoSmithKline.